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Two cell-associated forms of the glycoprotein (G) of vesicular stomatitis virus, 
termed G1 and G2, have been resolved by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis. G1 has the higher electrophoretic mobility, but both forms 
migrate more slowly than G protein synthesized in a wheat germ cell-free 
system (G0), which presumably is the unglycosylated form. G1 is a kinetic 
precursor of the G2 form, and the apparent cause of the electrophoretic difference 
between the two species is the presence of N-acetylneuraminic acid on the G2 
form. Conversion of G1 to G2 occurs 10 to 20 min prior to the appearance of the G2 
form of the protein on the cell surface. This suggests that the G protein may be 
completely glycosylated several minutes prior to its migration to the cell surface 
and that glycosylation is not the limiting step in its maturation. No glycoprotein 
comigrating with G0 can be detected in the infected cells, even after 5-min 
labeling periods; this suggests that partial glycosylation of G occurs concomi-
tantly with or immediately after its synthesis. 
The lipoprotein envelope of vesicular stoma-
titis virus (VSV) contains external spikes made 
of a single glycoprotein (G) embedded in a lipid 
bilayer (15). This structure surrounds the heli-
cal nucleocapsid of the virus, with the matrix 
(M) protein forming a layer between them (17, 
25). Because the virus matures by budding 
through the host cell plasma membrane, the 
glycoprotein appears to be inserted into the 
surface plasma membrane of the host cell. The 
G protein is synthesized on membrane-bound 
polyribosomes (4, 8, 16, 22) and is later found in 
the plasma membrane of the host cell, where it 
is picked up by the budding virus (10, 23, 33). 
We have separated two cytoplasmic species of 
the VSV G protein by sodium dodecyl sulfate 
(SDS)-polyacrylamide gel electrophoresis, the 
two species appearing to differ only in their 
content of sialic acid. We have utilized these 
two species as markers for the determination of 
the cellular sites of glycosylation and the rela-
tionship between glycosylation and the course 
of appearance of the G protein on the surface of 
infected cells. 
MATERIALS AND METHODS 
Growth of cells and virus. Chinese hamster ovary 
{CHO) cells were grown in suspension culture at 12 
x 10' to 40 x 1()4 cells/ml in Joklik modified minimal 
essential medium supplemented with 7% fetal calf 
serum and 1% nonessential amino acids. Mouse L 
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cells were grown in similar medium lacking nones-
sential amino acids and maintained at 40 x 1()4 to 80 
x 10' cells/mi. 
The wild-type stock of VSV used in this work was 
derived from the large plaque variant of VSV Indi-
ana isolated by Wagner et al. (24). All experiments 
were conducted with CHO cells. Virus stocks were 
prepared in L cells by infecting cells at 40 x 10'/ml 
with a multiplicity of 0.1 PFU/cell, using a stock 
prepared from plaque-purified virus (20). The infec-
tion was allowed to proceed for 20 h, the cells were 
removed by centrifugation, and the virus was puri-
fied as described previously (21). 
Protocol for infecting and labeling cultures. 
CHO cells were concentrated to 4 x 106 cells/ml in 
medium containing 1.8 mM CaCl2 , and virus was 
added to a multiplicity of 10 PFU/cell. Actinomycin 
D, the kind gift of Merck, Sharp, and Dohme, was 
added to 5 ~~og/ml. The culture was incubated for 30 
to 45 min and then diluted with 2 volumes of com-
plete medium. Cultures incubated at 31 or 39"C were 
buffered by the addition of 10 mM TES [N-Tris-
(hydroxylmethyl) - methyl - 2- aminoethanesulfonic 
acid] and 25 mM HEPES (N-2-hydroxylethylpiper-
azine-N'-2-ethanesulfonic acid), pH 7.4. 
Cultures were generally labeled at 4 h postinfec-
tion with [35S]methionine (New England Nuclear 
Corp.; 200 to 400 Ci/mmol) at 6 to 12 ~~oCilml. Prior to 
labeling, the cells were collected by centrifugation, 
washed with Earle saline solution, and resuspended 
at 2 x 106 cells/ml in methionine-free medium con-
taining 1% nonessential amino acids, 7% dialyzed 
fetal calf serum (18), and 10 mM TES-25 mM 
HEPES, pH 7.4. Chase conditions were established 
by the addition of 1 mM unlabeled methionine. For 
labeling with 3H-labeled sugars, the cells were col-
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lected and washed with phosphate-buffered saline 
(PBS; 7) and resuspended in glucose-free medium 
supplemented with 0.1 mg of glucose per ml and 10 
mM TES-25 mM HEPES, pH 7.4. 
Lactoperoxidase surface iodination of cells. Cells 
to be labeled were washed three times with PBS 
containing Ca2+ and Mg2+, and 107 cells were gener-
ally resuspended in 2 ml of PBS for the labeling 
reaction described by Sefton et al. (19). The follow-
ing components were added: Nal, 5 nmol; glucose, 10 
nmol; lactoperoxidase (Calbiochem), 20 JLg; Na'251 
(New England Nuclear Corp., carrier-free), 25 to 100 
JLCi; glucose oxidase (Worthington Biochemicals 
Corp.), 0.1 U. The reaction was allowed to proceed 
for 10 min at 25°C, and the tube containing the cells 
was placed on ice and 1 mM unlabeled Nal was 
added to stop the labeling reaction. The cells were 
then washed three times with PBS prior to protease 
treatment or gel electrophoresis. Protease treat-
ment (see below) was capable of removing greater 
than 80% of the acid-precipitable radioactivity from 
these iodinated cells, and separation of protease-
treated samples on SDS-polyacrylamide gels indi-
cated that the residual radioactivity must be in ma-
terial not within the molecular-weight range on the 
gel or in some other material such as glycolipids, 
etc. (see Fig. 4). This indicated that the labeling was 
largely restricted to proteins on the surface of the 
cells. 
Protease treatment of intact cells. After washing 
three times with PBS, cells were resuspended at 
approximately 107 cells/ml in PBS. Chymotrypsin 
(Worthington Biochemicals Corp.) was added to a 
final concentration of 1 mg/ml, and the cells were 
incubated at 37°C for 10 min. These conditions were 
shown to remove greater than 95% of the iodinated 
viral G protein on the surface of infected cells. After 
this incubation, phenylmethylsulfonyl fluoride 
(PMSF; Sigma Chemical Co.) was added to a final 
concentration of2 mM from a fresh stock solution of 
0.1 M in ethanol, and the cells were further incu-
bated for 1 to 5 min at 37°C. Chymotrypsin preincu-
bated with PMSF under these conditions prior to 
exposure to iodinated infected cells was completely 
inactivated, as shown by its inability to remove any 
iodinated viral G protein. This allowed inactivation 
of the protease after removal of the surface polypep-
tides, but prior to breaking open the cells for frac-
tionation or gel electrophoresis. 
SDS-polyacrylamide gel electrophoresis of pro-
teins. Labeled viral proteins were subjected to gel 
electrophoresis in 10% polyacrylamide slab gels by 
the method of Laemmli (12). To give maximal reso-
lution of the viral proteins, the gels were run for 45 
min after the bromophenol blue dye had reached the 
bottom of the gel. The slab gels were stained with 
Coomassie brilliant blue, destained, fixed in 10% 
acetic acid, and dried onto Whatman 540 paper. The 
dried gel was exposed to Kodak SB54 single-side 
emulsion, blue-sensitive X-ray film . For quantita-
tion, the autoradiogram was scanned on a Joyce-
Loeb! microdensitometer, and the areas under peaks 
were determined by using a Keufel and Esser pla-
nimeter. For the detection of 3H-labeled compounds, 
fluorography, using the method of Laskey and Mills 
(14), was performed. 
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RESULTS 
Intracellular forms of the VSV glycopro-
tein. To study the forms of the G protein in the 
cytoplasm of infected cells, infected cultures 
were labeled with [3;S]methionine for 5 min at 4 
h postinfection and chased for various periods of 
time, and the total cellular protein was ana-
lyzed by SDS-polyacrylamide gel electrophore-
sis (Fig. 1). After the pulse label, the G protein 
was observed as a single species, having an 
apparent molecular weight of 65,000, which we 
are calling G, . During the chase period, this 
species was progressively converted to a more 
slowly migrating species, called G2 , with an 
apparent molecular weight of 67,000. No 
changes in mobility of the other VSV proteins 
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Fxo. 1. Pulse-chase labeling of total cellular pro-
teins of cells infected with VSV. CHO cells were 
infected at a multiplicity of infection ofl 0 with VSV 
and incubated at 3rC. The culture was labeled for 5 
min at 4 h postinfection with [35S]methionine as de-
scribed in the text, and then excess unlabeled methio-
nine was added. Portions of the culture were removed 
at the times shown and transferred into cold Earle 
saline. The cells were washed and directly solubi-
lized in gel sample buffer, and the cellular proteins 
were resolved by gel electrophoresis on a 10% SDS-
polyacrylamide slab gel. The autoradiogram shown 
was a 3-day exposure of the dried gel . 
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increase during the first 10 min of chase, pre-
sumably as a result of completion of nascent 
chains. 
Both G, and G2 appeared to have molecular 
weights greater than that of the polypeptide 
synthesized in vitro under the direction of G 
mRNA (3, 11, 16). To investigate this question 
directly, the polypeptides made in a wheat 
germ cell-free system programmed with total 
VSV mRNA (Fig. 2b) were compared by slab 
gel electrophoresis with the proteins of in-
fected-cell membranes. The in vitro synthesized 
G protein, called G0 , migrated more rapidly 
than any G protein found in infected cells. Even 
after 2.5 min of labeling, the shortest feasible 
time, no G protein migrating with G0 could be 
observed (data not shown). Go has all of the 
methionine-containing tryptic peptides of G, or 
G2 (3, 4, 11, 16); therefore, its rapid migration 
relative to G1 and G2 presumably indicates a 
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none. If the extent of glycosylation is the sole 
difference between Go and G,, it would there-
fore appear that the G protein is glycosylated 
either during or very soon after its synthesis, so 
the G0 form is never evident in the cytoplasm 
of infected cells. 
We also examined the forms of the glycopro-
tein in virions and on the surface of infected 
cells (Fig. 2c to e). Virions contained only the 
G2 species (Fig. 2c), thus accounting for the 
difference in mobility between virion and cyto-
plasmic G previously observed by Kang and 
Prevec (9). In addition, lactoperoxidase-cata-
lyzed iodination of the surface of infected cells 
revealed a virus-specific protein comigrating 
with G2 (Fig. 2e). Thus, the only form of the G 
protein present on the surface of the cells was 
Gz, a result consistent with the acquisition of 
only G2 by virions as they bud. 
Carbohydrate content of G, and G2• To ex-
plore the nature of the difference between G, 
-GzG I 
Go 
c d e 
FIG. 2. Comparison of the electrophoretic mobilities of the various forms of the VSV glycoprotein on 10% 
SDS-polyacrylamide slab gels. (a) and (b) are from one gel, and ( c to e) are from a second gel (run in parallel) . 
(a) {""S]methionine-labeled cytoplasmic VSV proteins from intermediate density membranes ( p = 1 .175) of 
infected cells labeled for 30 min and chased for 30 min (10) -48-h exposure; (b) {""S]methionine-labeled 
proteins synthesized in a wheat germ cell-free extract in response to the addition of total cytoplasmic VSV 
mRNA, using the conditions of Morrison and Lodish (16) -16-h exposure; (c) {35S]methionine-labeled virion 
proteins -48-h exposure; (d) {""S]methionine-labeled total cellular proteins from infected cells labeled from 4 
to 4 .5 h postinfection- 48-h exposure; (e) 125/-labeled surface proteins of infected CHO cells- 48-h exposure. 
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and G2 , we labeled infected cells with 3H-la-
beled sugars. In cells labeled with [3H]glucosa-
mine for 30 min, two labeled bands were appar-
ent, comigrating with G, and G2 (Fig. 3). Both 
forms of G, therefore, appeared to be at least 
partially glycosylated. In addition, when cells 
were labeled with [3H]galactose, a sugar found 
only in the subterminal position in the major 
glycopeptides of the G protein of VSV grown in 
BHK cells (J. Etchison, personal communica-
tion), a band comigrating with G2 and a second 
band comigrating with G, or slightly behind it 
were found. These results suggested that the 
carbohydrates on G, and G2 are not very differ-
ent. 
To determine whether terminal sialic acid 
residues might be responsible for the electro-
phoretic differences between G, and G2 , the 
effect of neuraminidase treatment on their mo-
bility was investigated. Cells were pulse-labeled 
with [:15S]methionine for 15 min and chased for 
60 min with cold methionine to allow most of 
the labeled G protein to accumulate on the cell 
-Direction of miQrotoon 
FIG. 3. Analysis of the carbohydrate content of the 
G, and G2 species . Microdensitometer tracings of the 
G region offluorograms of10o/o slab gels on which the 
total cellular proteins were subjected to SDS-poly-
acrylamide gel electrophoresis from cultures incu-
bated with the indicated radioactive labels. 35S-met, 
[ 35S]methionine; 3H-glcNH2, D-[6- 3H]glucosamine 
(25 pCi/ml; New England Nuclear Corp.); 3H-gal, D-
{1-3H]galactose (25 pCi/ml; New England Nuclear 
Corp.). All cultures were labeled 4 to 4 .5 h postinfec-
tion in the appropriate medium (see text). Although 
not shown in the tracings, no radioactivity was incor-
porated into the other viral proteins in the case of the 
sugar labels . 
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surface (see below). The intact cells were then 
incubated with 50 units of neuraminidase per 
ml for 30 min at 37°C. Prior to the enzyme 
treatment, a large percentage of the G protein 
was in the G2 form (Fig. 4b). After the enzyme 
treatment of the cell surface, all of the protein 
comigrated with the G, species (Fig. 4c). Simi-
lar treatment of [3H]galactose-labeled cells 
showed a shift in mobility of the galactose-
labeled G2 species to the G, position, with no 
loss of radioactivity (data not shown). These 
results were supporting evidence that the en-
zyme preparation was not contaminated with 
other glycosidases, and no sugars other than 
sialic acid were removed. Incubation of VSV 
proteins synthesized in vitro with neuramini-
dase showed no degradation of the viral pro-
teins, especially G11 , demonstrating that there 
was no specific proteolytic activity in the prepa-
ration which was capable of removing a small 
L-
M-
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FIG. 4. Analyais of carbohydrate content of the G, 
and G2 species. Autoradiogram of a 10% slab gel on 
which the following samples were subjected to elec-
trophoresis: (a and d) total cellular proteins labeled 4 
to 4.5 h postinfection with [35S]methionine; (b) total 
cellular proteins from the cells labeled with 
[ 35S]methionine for 15 min, chased for 60 min, and 
incubated in PBS for 30 min at 37"C; (c) same as 
sample (b), except that incubation in PBS contained 
50 U of neuraminidase (Vibrio cholerae; Calbi-
ochem) per ml. 
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portion of the G protein (data not shown). We 
conclude that the difference in electrophoretic 
mobility between the G1 and G2 forms of the 
glycoprotein is due largely, if not completely, to 
the presence of N -acetylneuraminic acid resi-
dues on the G2 form. 
Movement of the G protein to the cell sur-
face. To develop an assay for the time of ap-
pearance of the G protein on the cell surface, we 
first used the ability of lactoperoxidase-cata-
lyzed iodination to label G protein on the in-
fected cell surface (Fig. 2e). Such 12"1-labeled 
surface G protein can be removed by protease 
treatment. In preliminary experiments, it was 
shown that treatment of intact cells with 1 mg 
of chymotrypsin per ml for 10 min at 37°C, 
followed by inhibition of the enzyme, was capa-
ble of removing more than 95% of the 12"1-la-
beled G protein from the cell surface (Fig. 5). 
Such treatment did not affect the pattern of 
Coomassie blue-stained cell proteins or of la-
beled N, NS, or L proteins in infected cells. 
These conditions were then used on 
[ 35S]methionine-labeled cells to determine 
5 min label 
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when G protein reaches the cell surface (i.e. , 
when G protein becomes sensitive to treatment 
of intact cells with protease). 
Cells were labeled with [35S]methionine for 5 
min and then chased for various periods of 
time. Samples were taken and half of each was 
treated with chymotrypsin. The treated and 
control samples were then analyzed in parallel 
by gel electrophoresis (Fig. 5). The amounts of 
G1 and G2 were quantitated, and the percentage 
of label in G2 as well as the percentage of G 
removed by protease was plotted (Fig. 6). As is 
most evident between 10 and 30 min of the 
chase, there was protein migrating as G2 that 
was not sensitive to protease treatment . The 
conversion of G1 to G2 had a half-time of about 
30 min, but there was a 10- to 20-min lag period 
before the G2 protein was converted to a pro-
tease-sensitive form. The protease-resistant G2 
did not appear to result from conversion of G1 to 
G2 and movement onto the surface during the 5-
min inactivation of chymotrypsin with PMSF 
because, in another experiment utilizing a 1-












FIG. 5. Time course of movement of the G protein to the cell surface . A culture of infected cells was exposed 
to {35S}methionine for 5 min at 4 h postinfection at 37°C. After the labeling period, excess unlabeled 
methionine was added and the incubation was continued at 37°C. At the times indicated , portions of the 
culture were removed and transferred into 4 volumes of ice-cold Earle saline. Each sample of cells was washed 
with PBS three times. The cells were resuspended in PBS, and one-halfofeach sample was incubated in PBS 
with I mg of chymotrypsin per ml at 37°C for 10 min while the remainder was incubated in PBS only for the 
same period. After this incubation, PMSF was added to 2 mM and incubation was continued for 5 min at 
3rC. The cells were washed with PBS and dissolved directly in gel sample buffer. The sample of iodinated 
cells was labeled as described in the text , using infected cells at 4 h postinfection . After the labeling reaction , 
the cells were extensively washed and suspended at the same concentration as the [35S]methionine-labeled cells 
in PBS for the protease treatment. The remainder of the protease reaction was conducted as above. The 
samples were subjected to SDS-polyacrylamide gel electrophoresis on 10% slab gels . The autoradiogram 
shown is from a 4-day exposure of the dried gel . 
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FIG. 6. Quantitation of the time course of the con-
version of a, to a. and appearance of total a protein 
on the cell surface. These data are from the experi-
ment shown in Fig. 5. Symbols: e, percentage of 
total a protein removed by protease treatment, nor-
malized relative to the amount of NS protein in each 
sample to account for differences in total material in 
each sample (the amount of a protein in each sample 
was determined by microdensitometry of the autora-
diogram shown in Fig. 5); 0, percentage of total a in 
a. form in the control sample for each time point. 
were obtained (data not shown). By 90 min of 
chase, all of the G protein was in the G2 form, 
and nearly 80% of it was removed by chymo-
trypsin and appeared to be on the surface of the 
cell. At all times, the G, protein was resistant 
to treatment of intact cells with protease. We 
conclude from these results that the G protein 
is probably completely glycosylated inside the 
infected cell at approximately 10 to 20 min prior 
to its exposure on the surface of the cell. Thus, 
glycosylation is not the limiting factor in the 
movement of G protein to the cell surface. 
DISCUSSION 
We have utilized SDS-polyacrylamide gel 
electrophoresis to separate two cytoplasmic spe-
cies of the VSV G protein, G, and G2. The G, 
form is made first and converted intracellularly 
into G2 , and G2 migrates to the external surface 
of the plasma membrane, from which it can be 
removed by proteases. We find that G protein 
does not appear on the cell surface until at least 
15 min after its synthesis, a much longer time 
than previously proposed by David (6). Because 
neuroaminidase could convert G2 to G~> the ap-
parent cause of the difference in mobility is the 
difference in sialic acid content. The large dif-
ference in mobility between G, and G. could be 
due to either the additional mass added by the 
sialic acid or the additional negative charge of 
the acidic residues. This could lower the bind-
ing of SDS to the glycoprotein and lessen its 
electrophoretic mobility. 
Either form of the glycoprotein could be het-
erogeneous in its carbohydrate content. The 
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protein could be sialylated to varying extents, 
but the various forms could migrate together as 
G2 • Similarly, G, might contain forms with het-
erogeneous carbohydrate chains, but with the 
heterogeneity not affecting the mobility. It is 
only clear that the G, band contains glycopro-
tein that has label from both galactose and 
glucosamine. 
The resolution of these two species has al-
lowed us to define the series of events involving 
the sialylation of the G protein and its migra-
tion onto the surface of infected cells. There 
appears to be a 10- to 20-min lag period between 
the addition of sialic acid and the appearance of 
the protein on the cell surface. 
Because sialic acid is the terminal sugar of 
the major glycopeptides of VSV (5), it would 
appear that these chains are nearly complete 
several minutes prior to the emergence of the 
protein on the surface of the cell. This would 
imply that the addition of sugars is not the 
limiting step in the maturation of the G pro-
tein. However, there could be additional glyco-
sylation or sialylation that we do not detect 
which limits maturation. Atkinson et al. (2) 
observed that the incorporation of fucose, con-
sidered to be the last sugar added to glycopro-
teins (1), occurs 20 min prior to the incorpora-
tion of the G protein into plasma membranes. 
They concluded similarly that glycosylation is 
not the limiting step in maturation of the G 
protein to the cell surface. 
Because we can resolve only these two cyto-
plasmic species of the G protein, we have very 
little information about the course of addition 
of internal sugars to the polypeptide chain. We 
did not observe any of the Go species in infected 
cells, and we therefore conclude that the early 
steps of glycosylation occur soon after or during 
synthesis of the polypeptide chain. However, 
the question of the nature of the difference 
between G0 and G, warrants further study. We 
cannot rule out the possibility that the Go is a 
premature termination product of the complete 
G protein. However, the fact that the 63,500-
molecular-weight protein (Go) is the major 
product of the G mRNA in several cell-free 
systems (3, 11, 16, 22) argues that this is the 
complete protein moiety of the glycoprotein. It 
remains to be conclusively demonstrated that 
the sole difference between G0 and G, is the 
presence of carbohydrate chains on G1• 
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